SCH00013, a novel Ca2+ sensitizer with positive inotropic and No chronotropic action in heart failure

被引:8
作者
Tadano, N
Morimoto, S [1 ]
Yoshimura, A
Miura, M
Yoshioka, K
Sakato, M
Ohtsuki, I
Miwa, Y
Takahashi-Yanaga, F
Sasaguri, T
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Clin Pharmacol, Fukuoka 8128582, Japan
[2] Zenyaku Kogyo Co Ltd, Res Lab, Tokyo 1780062, Japan
[3] Jikei Univ, Sch Med, Dept Physiol, Tokyo 1058461, Japan
关键词
Ca2+ sensitizer; skinned cardiac muscle fiber; sarcomere length; high-pacing; Frank-Starling mechanism;
D O I
10.1254/jphs.FP0040654
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We investigated the effects of the agent SCH00013 on C2+-induced force generation in rabbit skinned cardiac muscle fibers and in vivo cardiac function in high-pacing-induced heart failure dogs. The C2+-induced force generation in skinned cardiac muscle fibers was determined at pH 6.2 - 7.4, and SCH00013 was found to have a significant Ca2+ sensitizing effect at pH 7.2 to 7.4. There was no significant difference in the Ca2+ sensitizing action between the enantiomers of SCH00013. The Ca2+ sensitizing effect of SCH00013 was dependent on the sarcomere length, being significant only at a long sarcomere length. SCH00013 elicited a positive inotropic effect at more than 0.3 and 1 mg/kg, i.v. in normal and heart failure dogs, respectively, with no chronotropic action. These results strongly suggested that SCH00013 is a novel Ca2+ sensitizer that elicits a positive inotropic and no chronotropic effect in heart failure, probably through enhancing the Frank-Starling mechanism.
引用
收藏
页码:53 / 60
页数:8
相关论文
共 24 条
[1]   Attenuation of length dependence of calcium activation in myofilaments of transgenic mouse hearts expressing slow skeletal troponin I [J].
Arteaga, GM ;
Palmiter, KA ;
Leiden, JM ;
Solaro, RJ .
JOURNAL OF PHYSIOLOGY-LONDON, 2000, 526 (03) :541-549
[2]   A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure [J].
Cohn, JN ;
Goldstein, SO ;
Greenberg, BH ;
Lorell, BH ;
Bourge, RC ;
Jaski, BE ;
Gottlieb, SO ;
McGrew, F ;
DeMets, DL ;
White, BG .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (25) :1810-1816
[3]   Mechanism of action of Ca2+ sensitizers -: Update 2001 [J].
Endoh, M .
CARDIOVASCULAR DRUGS AND THERAPY, 2001, 15 (05) :397-403
[4]  
Endoh M, 2001, CARDIOVASC DRUG REV, V19, P345
[5]  
FUJINO K, 1988, J PHARMACOL EXP THER, V247, P519
[6]  
Fukuda N, 2000, CIRC RES, V86, pE1
[7]  
Hino M, 1999, ARZNEIMITTEL-FORSCH, V49, P398
[8]  
KATZ AM, 1986, CIRCULATION, V73, P184
[9]   MCI-154, a cardiac Ca2+ sensitizer, reverses the depression in maximal Ca2+-activated force by inorganic phosphate and acidic pH in skinned fiber of guinea pig heart [J].
Kitada, Y .
CARDIOVASCULAR DRUGS AND THERAPY, 1997, 11 (05) :611-618
[10]   A NOVEL THIADIZINONE DERIVATIVE FULLY REVERSES ACIDOSIS-INDUCED DEPRESSION OF FORCE IN CARDIAC-MUSCLE BY A CALCIUM-SENSITIZING EFFECT [J].
LEE, JA ;
SHAH, N ;
WHITE, J ;
ORCHARD, CH .
CLINICAL SCIENCE, 1993, 84 (02) :141-144